Free shipping on all orders over $ 500

MLN2238

Cat. No. M2285

All AbMole products are for research use only, cannot be used for human consumption.

MLN2238 Structure
Synonym:

Ixazomib

Size Price Availability Quantity
1mg USD 30 In stock
5mg USD 60 In stock
10mg USD 90 In stock
25mg USD 160 In stock
50mg USD 250 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MLN2238 is a potent reversible and specific β5 site of the 20S proteasome inhibitor with an IC50 value of 3.4 nM. Proteasome activity was significantly inhibited in both blood and tumor following a single dose of MLN2238 administered IV at 14 mg/kg or SC at 4 mg/kg. It is active in preclinical models of lymphoma, and that MLN2238 has antitumor activity in a model of lymphoma that is refractory to bortezomib treatment.

Customer Product Validations & Biological Datas
Source Cell Death Dis (2018). Figure 5. MLN2238
Method MTS assay
Cell Lines HepG2 a, Hep3B b, and SNU475 c cells
Concentrations 0-1000 nM
Incubation Time 24, 48, and 72 h
Results Fig. 1d shows that after 48 h MLN2238 significantly inhibited HCC cell proliferation according to the drug concentration.
Chemical Information
Molecular Weight 361.03
Formula C14H19BCl2N2O4
CAS Number 1072833-77-2
Solubility (25°C) DMSO 52 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] No authors listed. Ixazomib

[2] Giuseppa Augello, et al. Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

[3] Xinghua Wei, et al. MLN2238 synergizes BH3 mimetic ABT-263 in castration-resistant prostate cancer cells by induction of NOXA

[4] Aneel Paulus, et al. The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs

[5] Juan J Gu, et al. MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical mod䲧畸

Related Proteasome Products
Bortezomib (PS-341)

Bortezomib (PS-341) is a highly selective proteasome inhibitor with a ki value of 6nM.

CTP-518

CTP-518 is a novel HIV protease inhibitor. CTP-518 has the potential to be the first HIV protease inhibitor toeliminate the need to co-dose with a boosting agent.

ITMN-191

ITMN-191 (Danoprevir, RG7227) is a potent and orally active inhibitor of hepatitis C virus (HCV) NS3/4A serine protease with an IC50 of 1.6 nM.

MG132

MG132 is a specific and potent cell-permeable proteasome inhibitor (IC50 = 100 nM, Ki = 4 nM). MG-132 effectively blocks the proteolytic activity of the 26S proteasome complex. MG-132 is also a calpain inhibitor with IC50 of 1.2 μM.

IU1

IU1 is a reversible, small molecule inhibitor of deubiquitination by USP14 that demonstrates an IC50 value of 4-5 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: MLN2238, Ixazomib supplier, Proteasome, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.